The insider sales are too small in dollar terms and relative to market cap to warrant a bearish read. Monitor for any larger insider sales or a change in the pattern, but this cluster alone does not suggest material negative information.
LGND drugs
LGND drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 15 $276.98entry
- T+1 · 2mo ago −0.64%α −0.20% · $275.20
- T+5 · 8w ago +7.77%α +5.66% · $298.50
- T+20 · 5w ago +9.59%α +6.86% · $303.53
- T+44 · todayOpen
- T+60 · in 22d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at Ligand Pharmaceuticals sold a combined $427K in open-market transactions over a one-week window. The sales are small relative to the $5.7B market cap (0.007%), and the cluster consists of a CLO and a director, not the CEO or CFO, limiting the informational signal.
Key Financial Metrics
Key Facts
- Two insiders sold shares between Sept 3 and Sept 10, 2026
- Total sale value: $427K (0.007% of $5.7B market cap)
- Sellers: CLO Andrew Reardon ($85K) and Director Martine Zimmermann ($342K)
- No CEO or CFO sales in the cluster
- 94% of analysts rate the stock as Buy or Strong Buy
Financial Impact
Total insider sales of $427K represent a negligible 0.007% of market cap
Risk Factors
- Insider sales could accelerate if management becomes less confident
- The stock has high institutional ownership (BlackRock, Invesco, Vanguard), any large fund trim could pressure shares
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-LGND-1789419701379 |
Track record
29 reports on LGND
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +38.85% at T+60 after the Apr 14, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $305.74 Now $301.71 −1.32% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $306.47 Now $301.71 −1.55% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $316.27 Now $301.71 −4.60% settles Feb 10
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $316.83 Now $301.71 −4.77% settles Feb 9
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $314.16 Now $301.71 −3.96% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $314.15 Now $301.71 −3.96% settles Feb 5
- Nov 4, 202612d ago 144 Neutral 1/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers